IonQ (NYSE:IONQ) Shares Down 4.7% – Here’s What Happened

IonQ, Inc. (NYSE:IONQ) shares traded down 4.7% on Thursday. The company traded as low as $38.83 and last traded at $39.38. Approximately 22,785,207 shares traded hands during mid-day trading, a decline of 7% from the average daily volume of 24,561,234 shares. The stock had previously closed at $41.34.

More IonQ News

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: DARPA advances IonQ to the final stage of its quantum initiative. IonQ and IBM were selected for the next phase of the Defense Advanced Research Projects Agency’s Quantum Benchmarking Initiative. IonQ’s Stage C agreement could be worth up to $300 million as DARPA evaluates its approach to building large-scale, fault-tolerant quantum computers. The funding is subject to future appropriations, but the selection strengthens IonQ’s government credentials and could provide substantial validation and revenue. DARPA selects IBM and IonQ for next phase in development of fault-tolerant quantum computer
• Positive Sentiment: IonQ reported a quantum-memory interconnect milestone. The company said it achieved entanglement rates above 1,000 per second between a trapped-ion qubit and solid-state memory through a photonic interconnect. If scalable, the technology could help link separate quantum processors and support distributed quantum applications, potentially improving IonQ’s competitive positioning. IonQ Demonstrates World-First Quantum Memory-Enhanced Interconnect for Distributed Quantum Applications
• Neutral Sentiment: Analyst commentary remains generally favorable but should be treated cautiously. Articles cite positive average brokerage recommendations and IonQ’s growing order book, while comparisons with other technology stocks highlight its cash position and commercial traction. However, consensus recommendations may not fully reflect the company’s execution risks or valuation.
• Negative Sentiment: Valuation and execution concerns remain significant. IonQ remains unprofitable, with a negative net margin and expected full-year losses. Its stock is highly volatile, trades below its longer-term moving averages, and has faced questions about whether its market valuation is justified by current revenue and book value. DARPA funding beyond its initial commitment is not guaranteed, and competitive pressure across quantum computing could limit the eventual payoff.

Analyst Ratings Changes

IONQ has been the subject of a number of research analyst reports. Wall Street Zen cut IonQ from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 8th. Benchmark restated a “buy” rating and set a $60.00 target price on shares of IonQ in a research report on Thursday, August 6th. Bank of America assumed coverage on shares of IonQ in a research note on Monday, September 28th. They set a “buy” rating and a $60.00 price objective for the company. Jefferies Financial Group reissued a “buy” rating and set a $80.00 price target on shares of IonQ in a research report on Wednesday, September 9th. Finally, Wedbush reaffirmed an “outperform” rating and set a $75.00 price objective on shares of IonQ in a research note on Tuesday, September 22nd. Ten equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, IonQ presently has an average rating of “Moderate Buy” and a consensus price target of $63.83.

IonQ Price Performance

The firm has a market cap of $15.23 billion, a PE ratio of -8.58 and a beta of 3.36. The stock has a 50-day moving average price of $41.41 and a 200 day moving average price of $44.68.

IonQ (NYSE:IONQ) last released its earnings results on Wednesday, August 5th. The company reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.56) by $0.23. The firm had revenue of $80.05 million for the quarter, compared to the consensus estimate of $66.47 million. IonQ had a negative return on equity of 22.29% and a negative net margin of 553.27%. The firm’s revenue for the quarter was up 286.7% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.70) earnings per share. As a group, equities research analysts anticipate that IonQ, Inc. will post -2.11 earnings per share for the current year.

Insider Buying and Selling at IonQ

In related news, insider John Raymond sold 2,407 shares of the firm’s stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $37.21, for a total value of $89,564.47. Following the sale, the insider directly owned 77,741 shares of the company’s stock, valued at approximately $2,892,742.61. This trade represents a 3.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.55% of the stock is currently owned by insiders.

Hedge Funds Weigh In On IonQ

A number of hedge funds have recently made changes to their positions in IONQ. Archer Investment Corp acquired a new stake in shares of IonQ during the 2nd quarter worth $25,000. EverSource Wealth Advisors LLC grew its position in IonQ by 216.5% during the first quarter. EverSource Wealth Advisors LLC now owns 959 shares of the company’s stock valued at $28,000 after acquiring an additional 656 shares during the period. PeakShares LLC purchased a new stake in IonQ during the first quarter valued at about $29,000. EFG International AG acquired a new stake in IonQ during the second quarter worth about $30,000. Finally, MWA Asset Management purchased a new position in shares of IonQ in the 1st quarter worth about $32,000. Institutional investors and hedge funds own 41.42% of the company’s stock.

About IonQ

IonQ, Inc is a quantum computing company that develops and commercializes quantum computers based on trapped-ion technology. Its systems are designed to perform specialized computations that may eventually support applications in areas such as optimization, materials science, drug discovery, financial modeling and artificial intelligence.

The company offers access to its quantum processors through cloud platforms, including Amazon Web Services’ Amazon Braket, Microsoft Azure Quantum and Google Cloud.